Market Newsdesk

CORYDON, Ind., July 24, 2026 (GLOBE NEWSWIRE) — First Capital, Inc. (the “Company”) (NASDAQ: FCAP), the holding company for First Harrison Bank (the “Bank”), today reported net income of $4.8 million, or $1.43 per diluted share, for the quarter ended June 30, 2026, compared to net income of $3.8 million, or $1.13 per diluted share, for the quarter ended June 30, 2025.

Results of Operations for the Three Months Ended June 30, 2026 and 2025

Net interest income after provision for credit losses increased $1.6 million for the quarter ended June 30, 2026 compared to the same period in 2025. Interest income increased $1.6 million when comparing the two periods due to an increase in the average tax-equivalent yield⁽¹⁾ on interest-earning assets from 4.82% for the second quarter of 2025 to 5.12% for the same period in 2026, in addition to an increase in the average balance of interest-earning assets from $1.18 billion for the second quarter of 2025 to $1.24 billion for the same period in 2026. Interest expense decreased $93,000 when comparing the periods as the average cost of interest-bearing liabilities decreased from 1.64% for the quarter ended June 30, 2025 to 1.56% for the same period in 2026 while the average balance of interest-bearing liabilities increased from $883.8 million for the quarter ended June 30, 2025 to $907.3 million for the same period in 2026. As a result of the changes in interest-earning assets and interest-bearing liabilities, the tax-equivalent net interest margin⁽¹⁾ increased from 3.59% for the quarter ended June 30, 2025 to 3.98% for the same period in 2026. Refer to the accompanying average balance sheet for more information regarding changes in the composition of the Company’s balance sheet and resulting yields and costs from the quarter ended June 30, 2025 to the quarter ended June 30, 2026.

Based on management’s analysis of the Allowance for Credit Losses (“ACL”) on loans and unfunded loan commitments, the provision for credit losses increased from $306,000 for the quarter ended June 30, 2025 to $425,000 for the quarter ended June 30, 2026.   The Bank recognized net charge-offs of $58,000 and $113,000 for the quarters ended June 30, 2026 and 2025, respectively.

Noninterest income increased $187,000 for the quarter ended June 30, 2026 as compared to the quarter ended June 30, 2025. The increase is primarily due to the Company recognizing a $92,000 gain on equity securities during the quarter ended June 30, 2026 compared to a loss of $41,000 during the same period in 2025. In addition, the Company recognized an increase of $54,000 in service charges on deposit accounts when comparing the two periods.

Noninterest expenses increased $359,000 for the quarter ended June 30, 2026 as compared to the same period in 2025. This was primarily due to increases in compensation and benefits, advertising, and other expenses of $235,000, $84,000 and $79,000, respectively, when comparing the two periods.   The increase in compensation and benefits is due to increases in salary and wages associated with annual cost of living and performance related adjustments as well as increases in the cost of Company-provided health insurance benefits. The increase in advertising expenses is related to various new marketing campaigns undertaken during the quarter ended June 30, 2026. The increase in other expenses was primarily due to general inflationary pressures and routine pricing increases rather than any specific item. These increases were partially offset by a $75,000 decrease in professional services when comparing the two periods due to fewer consulting fees during the quarter ended June 30, 2026.  

Income tax expense increased $397,000 for the quarter ended June 30, 2026 as compared to the same period in 2025 resulting in an effective tax rate of 20.8% for the quarter ended June 30, 2026, compared to 18.4% for the same period in 2025. The increase in the Company’s effective tax rate for the quarter ended June 30, 2026 reflects a higher proportion of net income being subject to taxation compared to the same period last year.

Results of Operations for the Six Months Ended June 30, 2026 and 2025

For the six months ended June 30, 2026, the Company reported net income of $9.1 million, or $2.72 per diluted share, compared to net income of $7.0 million, or $2.09 per diluted share, for the same period in 2025.

Net interest income after provision for credit losses increased $3.4 million for the six months ended June 30, 2026 compared to the same period in 2025. Interest income increased $3.2 million when comparing the two periods due to an increase in the average tax-equivalent yield⁽¹⁾ on interest-earning assets from 4.73% for the six months ended June 30, 2025 to 5.04% for the same period in 2026, in addition to an increase in the average balance of interest-earning assets from $1.18 billion for the six months ended June 30, 2025 to $1.23 billion for the same period in 2026. Interest expense decreased $352,000 when comparing the periods as the average cost of interest-bearing liabilities decreased from 1.67% for the six months ended June 30, 2025 to 1.56% for the same period in 2026 while the average balance of interest-bearing liabilities increased from $883.2 million for the six months ended June 30, 2025 to $904.4 million for the same period in 2026. As a result of the changes in interest-earning assets and interest-bearing liabilities, the tax-equivalent net interest margin⁽¹⁾ increased from 3.47% for the six months ended June 30, 2025 to 3.90% for the same period in 2026. Refer to the accompanying average balance sheet for more information regarding changes in the composition of the Company’s balance sheet and resulting yields and costs from the six months ended June 30, 2025 to the six months ended June 30, 2026.

Based on management’s analysis of the ACL on loans and unfunded loan commitments, the provision for credit losses increased from $644,000 for the six months ended June 30, 2025 to $775,000 for the six months ended June 30, 2026. The Bank recognized net charge-offs of $169,000 and $197,000 for the six months ended June 30, 2026 and 2025, respectively.

Noninterest income increased $387,000 for the six months ended June 30, 2026 as compared to the six months ended June 30, 2025. The increase is primarily due to the Company recognizing a $270,000 gain on equity securities during the six months ended June 30, 2026 compared to a loss of $23,000 during the same period in 2025. In addition, the Company recognized increases of $70,000 and $53,000 in ATM and debit card fee income and service charges on deposit accounts, respectively, when comparing the two periods. These increases were partially offset by the Company recognizing a $92,000 loss on sale of available for sale securities for the six months ended June 30, 2026 compared to a loss of $55,000 for the same period in 2025. The loss on sale of available for sale securities during the six months ended June 30, 2026 was a result of management’s decision to sell $18.7 million of available for sale securities to better position the Company’s investment portfolio for increased future yields.

Noninterest expenses increased $931,000 for the six months ended June 30, 2026 as compared to the same period in 2025. This was primarily due to increases in compensation and benefits, other expenses, professional services, and advertising expenses of $470,000, $178,000, $166,000 and $82,000, respectively, when comparing the two periods. The increase in compensation and benefits is due to increases in salary and wages associated with annual cost of living and performance related adjustments as well as increases in the cost of Company-provided health insurance benefits. The increase in other expenses is primarily due to an increase in consumer fraud losses and increased support of the Company’s local communities through sponsorships and donations during the six months ended June 30, 2026 as compared to the same period in 2025.   The increase in professional services is due to increased consulting fees. The increase in advertising expenses is related to various new marketing campaigns undertaken during the six months ended June 30, 2026 as compared to the same period in 2025.

Income tax expense increased $755,000 for the six months ended June 30, 2026 as compared to the same period in 2025 resulting in an effective tax rate of 20.0% for the six months ended June 30, 2026, compared to 17.9% for the same period in 2025. The increase in the Company’s effective tax rate for the six months ended June 30, 2026 reflects a higher proportion of net income being subject to taxation compared to the same period last year.

Comparison of Financial Condition at June 30, 2026 and December 31, 2025

Total assets were $1.29 billion at June 30, 2026 compared to $1.27 billion at December 31, 2025. Net loans receivable and cash and cash equivalents increased $14.0 million and $12.5 million, respectively, from December 31, 2025 to June 30, 2026. These increases were partially offset by a decrease of $10.3 million in available for sale securities when comparing the two periods. Deposits increased $13.7 million from $1.12 billion at December 31, 2025 to $1.14 billion at June 30, 2026. Nonperforming assets (consisting of nonaccrual loans, accruing loans 90 days or more past due, and foreclosed real estate) increased from $4.4 million at December 31, 2025 to $4.9 million at June 30, 2026.

The Bank currently has 17 offices in the Indiana communities of Corydon, Edwardsville, Greenville, Floyds Knobs, Palmyra, New Albany, New Salisbury, Jeffersonville, Salem, Lanesville and Charlestown and the Kentucky communities of Shepherdsville, Mt. Washington and Lebanon Junction.

Access to First Harrison Bank accounts, including online banking and electronic bill payments, is available through the Bank’s website at www.firstharrison.com. For more information and financial data about the Company, please visit Investor Relations at the Bank’s aforementioned website. The Bank can also be followed on Facebook.

(1) Reconciliations of the non–U.S. Generally Accepted Accounting Principles (“GAAP”) measures are set forth at the end of this press release.

Cautionary Note Regarding Forward-Looking Statements

This press release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the use of the words “anticipate,” “believe,” “expect,” “intend,” “could” and “should,” and other words of similar meaning. Forward-looking statements are not historical facts nor guarantees of future performance; rather, they are statements based on the Company’s current beliefs, assumptions, and expectations regarding its business strategies and their intended results and its future performance.

Numerous risks and uncertainties could cause or contribute to the Company’s actual results, performance and achievements to be materially different from those expressed or implied by these forward-looking statements. Factors that may cause or contribute to these differences include, without limitation, general economic conditions, including changes in market interest rates and changes in monetary and fiscal policies of the federal government; competition; the ability of the Company to execute its business plan; legislative and regulatory changes; the quality and composition of the loan and investment portfolios; loan demand; deposit flows; changes in accounting principles and guidelines; and other factors disclosed periodically in the Company’s filings with the Securities and Exchange Commission.

Because of the risks and uncertainties inherent in forward-looking statements, readers are cautioned not to place undue reliance on them, whether included in this press release, the Company’s reports, or made elsewhere from time to time by the Company or on its behalf. These forward-looking statements are made only as of the date of this press release, and the Company assumes no obligation to update any forward-looking statements after the date of this press release.

Contact:

Joshua P. Stevens
Chief Financial Officer
812-738-1570

FIRST CAPITAL, INC. AND SUBSIDIARIES Consolidated Financial Highlights (Unaudited)
	Three Months Ended								Six Months Ended
	June 30,								June 30,
OPERATING DATA	2026				2025				2026				2025
(Dollars in thousands, except per share data)
Total interest income	$	15,622			$	14,040			$	30,546			$	27,386
Total interest expense		3,535				3,628				7,041				7,393
Net interest income		12,087				10,412				23,505				19,993
Provision for credit losses		425				306				775				644
Net interest income after provision for credit losses		11,662				10,106				22,730				19,349
Total non-interest income		2,205				2,018				4,253				3,866
Total non-interest expense		7,853				7,494				15,606				14,675
Income before income taxes		6,014				4,630				11,377				8,540
Income tax expense		1,249				852				2,279				1,524
Net income		4,765				3,778				9,098				7,016
Less net income attributable to the noncontrolling interest		3				3				6				6
Net income attributable to First Capital, Inc.	$	4,762			$	3,775			$	9,092			$	7,010
Net income per share attributable to
First Capital, Inc. common shareholders:
Basic	$	1.43			$	1.13			$	2.73			$	2.09
Diluted	$	1.43			$	1.13			$	2.72			$	2.09
Weighted average common shares outstanding:
Basic		3,336,190				3,346,653				3,336,134				3,346,751
Diluted		3,339,690				3,350,344				3,339,124				3,349,308
OTHER FINANCIAL DATA
Cash dividends per share	$	0.31			$	0.29			$	0.62			$	0.58
Return on average assets (annualized)		1.49	%			1.24	%			1.43	%			1.16	%
Return on average equity (annualized)		13.60	%			12.59	%			12.98	%			11.86	%
Net interest margin		3.91	%			3.52	%			3.82	%			3.40	%
Net interest margin (tax-equivalent basis) (1)		3.98	%			3.59	%			3.90	%			3.47	%
Interest rate spread		3.49	%			3.11	%			3.41	%			2.99	%
Interest rate spread (tax-equivalent basis) (1)		3.56	%			3.18	%			3.48	%			3.06	%
Net overhead expense as a percentage of average assets (annualized)		2.46	%			2.47	%			2.45	%			2.43	%

	June 30,				December 31,
BALANCE SHEET INFORMATION	2026				2025
Cash and cash equivalents	$	149,812			$	137,288
Interest-bearing time deposits		1,225				1,470
Investment securities		413,917				424,190
Gross loans		678,838				664,208
Allowance for credit losses		10,714				10,108
Earning assets		1,215,369				1,193,475
Total assets		1,290,041				1,271,995
Deposits		1,136,731				1,122,990
Stockholders’ equity, net of noncontrolling interest		142,510				137,797
Allowance for credit losses as a percentage of gross loans		1.58	%			1.52	%
Non-performing assets:
Nonaccrual loans		4,920				4,268
Accruing loans past due 90 days		—				83
Foreclosed real estate		—				—
Regulatory capital ratios (Bank only):
Community Bank Leverage Ratio (2)		11.34	%			11.01	%

______________________________

(1)  See reconciliation of GAAP and non-GAAP financial measures for additional information relating to the calculation of this item.
(2)  Effective March 31, 2020, the Bank opted in to the Community Bank Leverage Ratio (CBLR) framework. As such, the other regulatory ratios are no longer provided.

FIRST CAPITAL, INC. AND SUBSIDIARIES Consolidated Average Balance Sheets (Unaudited)
	For the Three Months ended June 30,
	2026										2025
								Average										Average
	Average							Yield/			Average							Yield/
	Balance			Interest				Cost			Balance			Interest				Cost
(Dollars in thousands)
Interest earning assets:
Loans (1) (2):
Taxable	$	661,948		$	10,675			6.45	%		$	643,824		$	10,165			6.32	%
Tax-exempt (3)		12,774			176			5.51	%			10,686			114			4.27	%
Total loans		674,722			10,851			6.43	%			654,510			10,279			6.28	%
Investment securities:
Taxable (4)		312,690			2,889			3.70	%			308,527			2,004			2.60	%
Tax-exempt (3)		119,056			902			3.03	%			118,418			842			2.84	%
Total investment securities		431,746			3,791			3.51	%			426,945			2,846			2.67	%
Interest bearing deposits with banks (5)		130,539			1,207			3.70	%			100,563			1,116			4.44	%
Total interest earning assets		1,237,007			15,849			5.12	%			1,182,018			14,241			4.82	%
Non-interest earning assets		42,055										34,037
Total assets	$	1,279,062									$	1,216,055
Interest bearing liabilities:
Interest-bearing demand deposits	$	442,178		$	1,203			1.09	%		$	440,186		$	1,334			1.21	%
Savings accounts		223,630			100			0.18	%			228,261			165			0.29	%
Time deposits		241,466			2,232			3.70	%			215,314			2,129			3.96	%
Total deposits		907,274			3,535			1.56	%			883,761			3,628			1.64	%
Total interest bearing liabilities		907,274			3,535			1.56	%			883,761			3,628			1.64	%
Non-interest bearing liabilities
Non-interest bearing deposits		219,031										202,365
Other liabilities		12,664										9,965
Total liabilities		1,138,969										1,096,091
Stockholders’ equity (6)		140,093										119,964
Total liabilities and stockholders’ equity	$	1,279,062									$	1,216,055
Net interest income (tax-equivalent basis)				$	12,314									$	10,613
Less: tax equivalent adjustment					(227	)									(201	)
Net interest income				$	12,087									$	10,412
Interest rate spread								3.49	%									3.11	%
Interest rate spread (tax-equivalent basis) (7)								3.56	%									3.18	%
Net interest margin								3.91	%									3.52	%
Net interest margin (tax-equivalent basis) (7)								3.98	%									3.59	%
Ratio of average interest earning assets to average interest bearing liabilities								136.34	%									133.75	%

______________________________

(1)  Interest income on loans includes fee income of $227,000 and $222,000 for the three months ended June 30, 2026 and 2025, respectively.
(2)  Average loan balances include loans held for sale and nonperforming loans.
(3)  Tax-exempt income has been adjusted to a tax-equivalent basis using the federal marginal tax rate of 21%.
(4)  Includes taxable debt and equity securities and FHLB Stock.
(5)  Includes interest-bearing deposits with banks and interest-bearing time deposits.
(6)  Stockholders’ equity attributable to First Capital, Inc.
(7)  Reconciliations of the non–U.S. GAAP measures are set forth at the end of this press release.

FIRST CAPITAL, INC. AND SUBSIDIARIES Consolidated Average Balance Sheets (Unaudited)
	For the Six Months ended June 30,
	2026										2025
								Average										Average
	Average							Yield/			Average							Yield/
	Balance			Interest				Cost			Balance			Interest				Cost
(Dollars in thousands)
Interest earning assets:
Loans (1) (2):
Taxable	$	660,861		$	21,030			6.36	%		$	638,326		$	19,849			6.22	%
Tax-exempt (3)		11,517			285			4.95	%			10,786			228			4.23	%
Total loans		672,378			21,315			6.34	%			649,112			20,077			6.19	%
Investment securities:
Taxable (4)		315,200			5,626			3.57	%			309,248			3,864			2.50	%
Tax-exempt (3)		119,093			1,792			3.01	%			118,650			1,663			2.80	%
Total investment securities		434,293			7,418			3.42	%			427,898			5,527			2.58	%
Interest bearing deposits with banks (5)		122,624			2,249			3.67	%			98,723			2,179			4.41	%
Total interest earning assets		1,229,295			30,982			5.04	%			1,175,733			27,783			4.73	%
Non-interest earning assets		43,940										31,697
Total assets	$	1,273,235									$	1,207,430
Interest bearing liabilities:
Interest-bearing demand deposits	$	439,812		$	2,367			1.08	%		$	439,952		$	2,743			1.25	%
Savings accounts		223,502			199			0.18	%			226,842			328			0.29	%
Time deposits		241,060			4,475			3.71	%			216,418			4,322			3.99	%
Total deposits		904,374			7,041			1.56	%			883,212			7,393			1.67	%
Total interest bearing liabilities		904,374			7,041			1.56	%			883,212			7,393			1.67	%
Non-interest bearing liabilities
Non-interest bearing deposits		216,123										198,218
Other liabilities		12,603										7,804
Total liabilities		1,133,100										1,089,234
Stockholders’ equity (6)		140,135										118,196
Total liabilities and stockholders’ equity	$	1,273,235									$	1,207,430
Net interest income (tax-equivalent basis)				$	23,941									$	20,390
Less: tax equivalent adjustment					(436	)									(397	)
Net interest income				$	23,505									$	19,993
Interest rate spread								3.41	%									2.99	%
Interest rate spread (tax-equivalent basis) (7)								3.48	%									3.06	%
Net interest margin								3.82	%									3.40	%
Net interest margin (tax-equivalent basis) (7)								3.90	%									3.47	%
Ratio of average interest earning assets to average interest bearing liabilities								135.93	%									133.12	%

______________________________

(1)  Interest income on loans includes fee income of $419,000 and $358,000 for the six months ended June 30, 2026 and 2025, respectively.
(2)  Average loan balances include loans held for sale and nonperforming loans.
(3)  Tax-exempt income has been adjusted to a tax-equivalent basis using the federal marginal tax rate of 21%.
(4)  Includes taxable debt and equity securities and FHLB Stock.
(5)  Includes interest-bearing deposits with banks and interest-bearing time deposits.
(6)  Stockholders’ equity attributable to First Capital, Inc.
(7)  Reconciliations of the non–U.S. GAAP measures are set forth at the end of this press release.

RECONCILIATION OF GAAP AND NON-GAAP FINANCIAL MEASURES (UNAUDITED):

This presentation contains financial information determined by methods other than in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Management uses these “non-GAAP” measures in its analysis of the Company’s performance. Management believes that these non-GAAP financial measures allow for better comparability with prior periods, as well as with peers in the industry who provide a similar presentation, and provide a further understanding of the Company’s ongoing operations. These disclosures should not be viewed as a substitute for operating results determined in accordance with GAAP, nor are they necessarily comparable to non-GAAP performance measures that may be presented by other companies. The following table summarizes the non-GAAP financial measures derived from amounts reported in the Company’s consolidated financial statements and reconciles those non-GAAP financial measures with the comparable GAAP financial measures.

	Three Months Ended								Six Months Ended
	June 30,								June 30,
	2026				2025				2026				2025
(Dollars in thousands)
Net interest income (A)	$	12,087			$	10,412			$	23,505			$	19,993
Add: Tax-equivalent adjustment		227				201				436				397
Tax-equivalent net interest income (B)		12,314				10,613				23,941				20,390
Average interest earning assets (C)		1,237,007				1,182,018				1,229,295				1,175,733
Net interest margin (A)/(C)		3.91	%			3.52	%			3.82	%			3.40	%
Net interest margin (tax-equivalent basis) (B)/(C)		3.98	%			3.59	%			3.90	%			3.47	%
Total interest income (D)	$	15,622			$	14,040			$	30,546			$	27,386
Add: Tax-equivalent adjustment		227				201				436				397
Total interest income tax-equivalent basis (E)		15,849				14,241				30,982				27,783
Average interest earning assets (F)		1,237,007				1,182,018				1,229,295				1,175,733
Average yield on interest earning assets (D)/(F); (G)		5.05	%			4.75	%			4.97	%			4.66	%
Average yield on interest earning assets tax-equivalent (E)/(F); (H)		5.12	%			4.82	%			5.04	%			4.73	%
Average cost of interest bearing liabilities (I)		1.56	%			1.64	%			1.56	%			1.67	%
Interest rate spread (G)-(I)		3.49	%			3.11	%			3.41	%			2.99	%
Interest rate spread tax-equivalent (H)-(I)		3.56	%			3.18	%			3.48	%			3.06	%

HAVERTOWN, Pa., July 24, 2026 (GLOBE NEWSWIRE) — AMREP Corporation (NYSE:AXR) today reported net income of $10,288,000, or $1.91 per diluted share, for its 2026 fiscal year ended April 30, 2026 compared to net income of $12,716,000, or $2.37 per diluted share, for the same period of the prior year. Revenues were $52,847,000 for fiscal 2026 and $49,694,000 for fiscal 2025.

More information about the Company’s financial performance in 2026 and 2025 may be found in AMREP Corporation’s financial statements on Form 10-K which have today been filed with the Securities and Exchange Commission and will be available on AMREP’s website (www.amrepcorp.com/sec-filings/). As a result of many factors, including the nature and timing of specific transactions and the type and location of land or homes being sold, revenues, average selling prices and related gross margins from land sales or home sales can vary significantly from period to period and prior results are not necessarily a good indication of what may occur in future periods.

AMREP Corporation, through its subsidiaries, is a major holder of land, leading developer of real estate and award-winning homebuilder in New Mexico.

FINANCIAL HIGHLIGHTS
		Twelve Months Ended April 30,
		2026			2025
Revenues		$	52,847,000		$	49,694,000
Net income		$	10,288,000		$	12,716,000
Income per share – basic		$	1.93		$	2.39
Income per share – diluted		$	1.91		$	2.37
Weighted average number of common shares outstanding – basic			5,337,000			5,318,000
Weighted average number of common shares outstanding – diluted			5,393,000			5,369,000

CONTACT:
Adrienne M. Uleau
Chief Financial Officer and Vice President
(610) 487-0907

BROOMFIELD, Colo., July 24, 2026 (GLOBE NEWSWIRE) — Gogo Inc. (NASDAQ: GOGO), the leading global provider of broadband connectivity services for the business aviation, military, and government markets, announced today that it will release its second quarter 2026 financial results before the market opens on August 6, 2026. The Company will host a conference call with financial analysts on the same day at 8:30 a.m. (ET).

Conference call & webcast

A webcast of the conference call and a replay will be available online on the Investor Relations section of the Company’s investor website at https://ir.gogoair.com/

Gogo 2Q 2026 Earnings Call – participants can join the webcast through this link
https://edge.media-server.com/mmc/p/czisjqz9

Participants can use the link below to retrieve a unique conference ID to access the conference call.
https://register-conf.media-server.com/register/BIc1371241a7b64561b1ebf76042a13f3b

About Gogo

Gogo is the only multi-orbit, multi-band in-flight connectivity provider offering connectivity technology purpose-built for business and military/government aviation. Its industry-leading product portfolio offers best-in-class solutions for all aircraft types, from small to large and heavy jets and beyond.

The Gogo offering uniquely incorporates air-to-ground systems with access to high-speed satellite networks, which aim to deliver consistent, global tip-to-tail connectivity through a sophisticated suite of software, hardware, and advanced infrastructure supported by a 24/7/365 in-person customer support team.

Gogo consistently strives to set new standards for reliability, security, and innovation and is shaping the future of inflight aviation to make it easier for every customer to stay connected beyond all expectations.

Investor Relations Contact:	Media Relations Contact:
Amy Greene +1 303-301-3313 [email protected]	Stacey Giglio +1 321-361-6101 [email protected]

                                

NOVATO, Calif., July 24, 2026 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of 65,886 restricted stock units of the company’s common stock to 39 newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company’s board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of July 16, 2026, as an inducement material to the new employees entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635(c)(4).

The restricted stock units vest over four years, with 25% of the underlying shares vesting on each anniversary of the grant date, subject to the employee being continuously employed by the company as of such vesting dates.

About Ultragenyx Pharmaceutical Inc.

Ultragenyx is a biopharmaceutical company committed to bringing novel products to patients for the treatment of serious rare and ultrarare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease.

The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx’s strategy is predicated upon time- and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency.

For more information on Ultragenyx, please visit the company’s website at: www.ultragenyx.com.

Contact Ultragenyx
Investors & Media
Joshua Higa
(415) 475-6370

DAVENPORT, Iowa, July 24, 2026 (GLOBE NEWSWIRE) — Lee Enterprises, Incorporated (NASDAQ: LEE), a major subscription and advertising platform and a leading provider of high quality, trusted, local news and information in 114 markets, has scheduled an audio webcast and conference call for Thursday, August 6, 2026, at 9 a.m. Central Time. Lee plans to issue a news release before the market opens that day with preliminary results for its quarter ended June 28, 2026.

A live webcast of the conference call may be accessed via the Investor Relations portion of Lee’s website or here. To participate in the live conference call via telephone, please register here. Upon registering, a dial-in number and unique PIN will be provided to join the conference call.

The live webcast will be accessible at lee.net and will be available for replay 24 hours later.

ABOUT LEE

Lee Enterprises is a leading provider of local news and information and a major subscription and advertising platform, with daily and weekly newspapers and rapidly expanding digital products serving 114 markets across 25 states. Lee’s markets include St. Louis, MO; Buffalo, NY; Omaha, NE; Richmond, VA; Lincoln, NE; Madison, WI; Davenport, IA; and Tucson, AZ. Lee Common Stock is traded on NASDAQ under the symbol LEE. For more information about Lee, please visit www.lee.net.

Contact:
[email protected]
(563) 383-2100

Company has sold six properties in 2026 

Remaining four properties are under contract, including new purchase and sale

agreement covering Riverside Apartments

Targets completion of all remaining sales during the third and fourth quarters of 2026 with delisting and dissolution targeted for fourth quarter 2026

Updates range of total estimated liquidating distributions to $16.41 – $16.61 per share (including the initial $14.67 per share distribution paid in January 2026)

BETHESDA, Md., July 24, 2026 (GLOBE NEWSWIRE) — Elme Communities (“Elme” or the “Company”) (NYSE: ELME) today provided an update regarding the status of ongoing liquidation activities under the Company’s Plan of Sale and Liquidation, approved by Elme shareholders on October 30, 2025.

Marketing and Sale Process

To date in 2026, the Company has completed the sale of six of its remaining properties – five of its multifamily properties, Elme Sandy Springs, Elme Marietta, Elme Conyers, Elme Germantown and Elme Watkins Mill, and its remaining office property, Watergate 600 – for aggregate gross proceeds of approximately $294 million.

As previously disclosed, in May 2026 the Company had entered into a purchase and sale agreement for Riverside Apartments (including related undeveloped land) which was subject to an ongoing inspection period and, on June 17, 2026, the buyer under that purchase and sale agreement exercised its right to terminate. On July 23, 2026, the Company entered into a purchase and sale agreement for Riverside Apartments with a new purchaser, which had previously submitted a proposal to acquire the property, for a contract sale price of $250.0 million, subject to certain customary adjustments and prorations. This new purchase and sale agreement is subject to an ongoing inspection period, as well as satisfaction of customary closing conditions. The new purchase and sale agreement for Riverside Apartments provides that, subject to completion of the inspection period and the satisfaction of the closing conditions, the sale of Riverside Apartments will close no later than September 14, 2026.

The existing purchase and sale agreements with respect to Elme Bethesda, The Kenmore and 3801 Connecticut Avenue, which provide for gross proceeds of approximately $168 million in the aggregate (subject to certain customary adjustments and prorations), are no longer subject to ongoing inspection periods, but remain subject to satisfaction of customary closing conditions including, in the case of the two DC properties, regulatory requirements related to the Tenant Opportunity to Purchase Act (TOPA). The closing of each DC property is expected to occur shortly after completion of its TOPA process, subject to satisfaction of other applicable closing conditions. The buyer of each DC property has commenced discussions with the property’s tenant association, and, assuming no purchase rights are exercised or assigned to a party other than the contract buyer, Elme currently anticipates the TOPA process for both properties to be completed no later than the end of 2026. The Company has obtained the certificate of compliance from the Montgomery County Department of Housing and Community Affairs certifying compliance with Montgomery County’s right of first refusal requirements with respect to Elme Bethesda, and, following receipt of such certificate, the parties to the purchase and sale agreement for Elme Bethesda have agreed to close the sale no later than August 11, 2026. 

Estimated Range of Liquidating Distributions

As previously disclosed, following closing of the 19-property portfolio sale to an affiliate of Cortland Partners LLC (the “Portfolio Sale”) and entry into a $520 million senior secured term loan with Goldman Sachs Bank USA, as lender (the “Term Loan”), both of which occurred on November 12, 2025, Elme’s Board of Trustees (the “Board”) declared an initial special liquidating distribution of $14.67 per common share, which was paid on January 7, 2026 to Elme shareholders of record on December 22, 2025 (the “Initial Liquidating Distribution”). A portion of the Term Loan has been repaid using a portion of the net proceeds from the sales of the six properties sold by the Company in 2026 to date, each of which had secured the Term Loan. The remaining outstanding balance of the Term Loan, which was $251 million as of July 23, 2026, is intended to be repaid using a portion of the net proceeds from the sales of the remaining properties which secure the Term Loan, and such properties are expected to be released from the mortgages securing the Term Loan as they are sold. The Company intends to return net proceeds from the sales of its assets to Elme shareholders when appropriate and in the Board’s discretion.

Based on the assumptions and estimates described in more detail below, the Company currently estimates that the total amount of additional liquidating distributions (the “Additional Liquidating Distributions”) to be funded from the net proceeds of sales of the Company’s remaining assets will be between $1.74 and $1.94 per common share. Based on this updated estimate, the total amount of liquidating distributions (including the Initial Liquidating Distribution) is estimated to be between $16.41 and $16.61 per common share. In May 2026, the Company had announced an estimate of the total amount of liquidating distributions (including the Initial Liquidating Distribution) of $16.74 to $17.02 per common share, which was in part based on the contract price under the then-in-place purchase and sale agreement for Riverside Apartments (the “May Liquidation Update”). However, following the June 17, 2026 termination of the Riverside Apartments purchase and sale agreement described above, the Company withdrew the previously provided estimated ranges of liquidating distributions included in the May Liquidation Update and announced that it expected to provide an update to its estimated ranges of liquidating distributions after it had entered into a new purchase and sale agreement for Riverside Apartments.   

The change in the estimated range of Additional Liquidating Distributions compared to the estimated range in the May Liquidation Update is predominantly the result of a reduction in the contract price for Riverside Apartments as reflected in the purchase and sale agreement with the new purchaser. Current market conditions in the D.C. area, which have remained subject to prolonged softening throughout our marketing and sale process generally, as well as the need to re-engage with potential purchasers for Riverside Apartments and the relatively smaller pool of potential purchasers for larger assets like Riverside Apartments, all had negative impacts on contract pricing for that asset. The adjusted estimated range of Additional Liquidating Distributions also includes increased estimates for general and administrative expenses as a result of the change in timeline for completion of the remaining sales and the termination and dissolution of the Company and increased estimates for other anticipated liquidation and other expenses, adjustments for incremental increases in estimated debt service costs, and the previously disclosed reduction in contract price for Elme Bethesda, partially offset by increases in the estimated cash flow/net working capital to be generated from the Company’s property operations through their estimated sale completion dates, as updated to reflect current estimates of the timing of sales of the remaining properties.

Our estimates of the ranges of liquidating distributions, including the updated estimated range of Additional Liquidating Distributions in this press release, were derived from a number of assumptions and estimates, including actual gross and net proceeds for the six properties that have been sold, estimated gross proceeds, including those discussed above, from the sales of the remaining properties under contract, less estimates for transaction costs, debt service costs, debt repayment amounts for the remaining outstanding balance of the Term Loan and establishment of reserves to satisfy liabilities and liquidating expenses, estimated operating costs to run the Company until completion of the wind-down of the Company’s business and affairs and dissolution of the Company, capital expenditure requirements and REIT compliance costs, but adjusted upwards for estimated cash flow/net working capital to be generated from the Company’s property operations prior to completing the sales of its remaining properties, including the updates to such assumptions and estimates described in this press release.

Many of the assumptions and estimates reflected in the updated estimated range of Additional Liquidating Distributions are outside the Company’s control, such as the completion of the regulatory processes for the sale of multifamily assets in DC on the timeline anticipated, and may not prove to be accurate, which could cause actual liquidating distributions, including the updated estimated range of Additional Liquidating Distributions, to be less or more than the estimated ranges. The Company cannot determine the timing of any Additional Liquidating Distributions to Elme shareholders or provide assurances that the actual amounts available for distribution to shareholders will be within the estimated ranges of the liquidating distributions, including the updated estimated range of Additional Liquidating Distributions set forth in this press release. Elme may provide further updates regarding any assumptions or estimates that may change in the future, but undertakes no obligation to do so.

For additional detail and other information regarding the assumptions and estimates relating to the updated estimated range of Additional Liquidating Distributions, please see the Current Report on Form 8-K, dated as of July 24, 2026, filed by Elme with the Securities and Exchange Commission (“SEC”), which is available free of charge through the website maintained by the SEC at http://www.sec.gov. Copies of the documents filed by Elme with the SEC are also available, free of charge, on Elme’s website at www.elmecommunities.com or upon written request to Investor Relations, Elme Communities, 7550 Wisconsin Ave, Suite 900, Bethesda, MD 20814.

Anticipated Timing of NYSE Delisting and Company Dissolution

While the New York Stock Exchange (“NYSE”) has discretionary authority to delist the Company’s common shares following shareholder approval of the Plan of Sale and Liquidation, Elme intends for its common shares to continue to be listed on the NYSE, subject to continued compliance with NYSE listing requirements, until such time in the future as the Board determines to voluntarily delist its common shares from the NYSE in order to reduce operating expenses and maximize liquidating distributions. Elme does not currently expect to voluntarily delist prior to completing the sale of Riverside Apartments and repayment of the Term Loan, and – assuming completion of the property sales as described above – currently expects the NYSE delisting and Company dissolution process to occur in the fourth quarter of 2026. It is the Company’s current expectation that, prior to delisting, the Company would make an Additional Liquidating Distribution in an amount to be determined by the Board. However, as noted above, the amount and timing of all additional liquidating distributions remains subject to the Board’s discretion. The Company anticipates that following its last day of trading on the NYSE, the Company’s share transfer books will be closed and all remaining assets (including any unsold properties at that time) and liabilities of the Company will be transferred to a liquidating trust, the outstanding common shares of the Company and all certificates representing such common shares will be deemed cancelled and the Company will be dissolved.

If the Company forms a liquidating trust, all shareholders of the Company at the time of its dissolution will be deemed to be beneficial owners of a pro rata share of the aggregate beneficial interests of the liquidating trust. These interests will generally not be transferable by the Company’s shareholders (except by will, intestate succession or operation of law). While the Board currently intends to take the actions as outlined above, consistent with the Plan of Sale and Liquidation, the timing of these actions remains subject to change, including as a result of any changes in the timing of property sale closings. In addition, the Board may modify or delay these actions if it determines that doing so is in the best interest of the Company and our shareholders.

The Company will provide additional details regarding the timing of delisting, the transfer of assets and liabilities into a liquidating trust and the dissolution of the Company, as well as the timing and amount of any Additional Liquidating Distribution to be made in connection with such events, in accordance with applicable requirements.

Forward-Looking and Cautionary Statements

Certain statements in this press release are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and involve risks and uncertainties. Forward-looking statements relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar expressions concerning matters that are not historical facts. In some cases, you can identify forward looking statements by the use of forward-looking terminology such as “may,” “will,” “should,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” or “potential” or the negative of these words and phrases or similar words or phrases which are predictions of or indicate future events or trends and which do not relate solely to historical matters. Such statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of Elme to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Additional factors which may cause the actual results, performance, or achievements of Elme to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements include, but are not limited to: Elme’s ability to remain listed on the NYSE and its expected timeline for doing so; Elme’s ability to transfer its remaining assets and liabilities to a liquidating trust and terminate its existence by voluntary dissolution on the terms and timeline anticipated; Elme’s ability to successfully complete the sales of its remaining assets, including successful completion of any remaining inspection periods and all closing conditions applicable to assets under contract, including, but not limited to, timely completion of the TOPA process for the sale of multifamily assets in DC, on the terms and timeline anticipated, or at all; changes in the amount and timing of the Additional Liquidating Distributions, including as a result of unexpected levels of transaction, general and administrative and other liquidation costs, changes in the gross asset sales proceeds for the sale of the remaining properties from prior estimates, delayed or terminated closings, liquidation costs or unpaid or additional liabilities and obligations; Elme’s ability to repay the Term Loan with the net proceeds from the sales of the remaining properties which secure the Term Loan and to release the mortgages securing the Term Loan as they are sold; the possibility, mechanics and timing of converting to a liquidating trust or other liquidating entity; the ability of Elme’s Board to terminate the Plan of Sale and Liquidation; the response of Elme’s residents, tenants and business partners to the Plan of Sale and Liquidation; potential difficulties in employee retention as a result of the on-going Plan of Sale and Liquidation; the outcome of legal proceedings that may be instituted against Elme, its trustees and others, including those related to the Portfolio Sale, completed and future property sales and the Plan of Sale and Liquidation; the risk that disruptions caused by or relating to the Plan of Sale and Liquidation will harm Elme’s business, including current plans and operations; risks relating to the market value of Elme’s common shares; risks associated with third party contracts containing consent and/or other provisions that may be triggered by the Plan of Sale and Liquidation; general risks affecting the real estate industry and local real estate markets (including, without limitation, the market value of Elme’s properties and potential illiquidity of Elme’s remaining real estate investments); whether or not the sale of one or more of Elme’s properties may be considered a prohibited transaction under the Internal Revenue Code of 1986, as amended; Elme’s ability to maintain its status as a real estate investment trust for U.S. federal income tax purposes; the occurrence of any event, change or other circumstances that could give rise to the termination of the Plan of Sale and Liquidation; the risks associated with ownership of real estate in general and Elme’s real estate assets in particular; general economic and market developments and conditions; and volatility and uncertainty in the financial markets.

The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties that affect Elme’s businesses in the “Risk Factors” section of Elme’s Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and other documents filed by Elme from time to time with the SEC, including the Form 8-K filed on July 24, 2026, referenced above. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. While forward-looking statements reflect Elme’s good faith beliefs, they are not guarantees of future performance. Elme undertakes no obligation to update its forward-looking statements or risk factors to reflect new information, future events, or otherwise.

Investor Relations
202-774-3200 

ORLANDO, Fla., July 24, 2026 (GLOBE NEWSWIRE) — IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2026 second quarter financial results before the market opens on Friday, July 31, 2026. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions.

Individuals interested in participating in the conference call may do so by registering here, https://register-conf.media-server.com/register/BIc3b3caa4c4d94098970951ede5eb5d2e Once registered, a dial-in number, unique pin, and instructions will be provided to participants.

The conference call will also be available real-time via the internet at http://www.iradimed.com/en-us/investors/events/. A recording of the call will be available on the Company’s website following the completion of the call.

About IRADIMED CORPORATION

IRADIMED CORPORATION is a leader in developing innovative Magnetic Resonance Imaging (“MRI”) compatible medical devices. We design, manufacture, market, and distribute MRI-compatible medical devices, accessories, disposables, and related services.

We are the only known provider of a non-magnetic intravenous (“IV”) infusion pump system specifically designed to be safe for use during MRI procedures. We were the first to develop an infusion delivery system that largely eliminates many of the dangers and problems present during MRI procedures. Standard infusion pumps contain magnetic and electronic components that can create radio frequency interference and are dangerous to operate in the presence of the powerful magnet that drives an MRI system. Our patented MRidium® MRI compatible IV infusion pump systems (3860 and 3870) have a non-magnetic ultrasonic motor, uniquely designed non-ferrous parts, and other special features to safely and predictably deliver anesthesia and other IV fluids during various MRI procedures. Our pump solutions provide a seamless approach that enables accurate, safe, and dependable fluid delivery before, during, and after an MRI scan, which is essential to critically ill patients who cannot be removed from their vital medications and children and infants who must generally be sedated to remain immobile during an MRI scan.

Our 3880 MRI compatible patient vital signs monitoring system has been designed with non-magnetic components and other special features to safely and accurately monitor a patient’s vital signs during various MRI procedures. The Iradimed 3880 system operates dependably in magnetic fields up to 30,000 gauss, which means it can operate virtually anywhere in the MRI scanner room. The Iradimed 3880 has a compact, lightweight design, allowing it to travel with the patient from the critical care unit to the MRI and back, resulting in increased patient safety through uninterrupted vital signs monitoring and decreasing the amount of time critically ill patients are away from critical care units. The features of the Iradimed 3880 include wireless ECG with dynamic gradient filtering; wireless SpO2 using Masimo® algorithms; non-magnetic respiratory CO2; invasive and non-invasive blood pressure; patient temperature, and optional advanced multi-gas anesthetic agent unit featuring continuous Minimum Alveolar Concentration measurements. The Iradimed 3880 MRI compatible patient vital signs monitoring system has an easy-to-use design and allows for the effective communication of patient vital signs information to clinicians.

For more information, please visit www.iradimed.com.

Media Contact:
John Glenn
Chief Financial Officer
IRADIMED CORPORATION
(407) 677-8022
[email protected]

CHANDLER, Ariz., July 24, 2026 (GLOBE NEWSWIRE) — (NASDAQ: MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that it has signed a definitive agreement to acquire Hailo, a provider of accelerated edge AI processors, advanced vision processing solutions, robotics processors and comprehensive AI software flows. The transaction is expected to close towards the end of the current quarter ending September 30, subject to customary closing conditions and regulatory approvals. The terms of the transaction are not being disclosed and the transaction is not expected to have a material impact on Microchip’s financial results.

The proposed acquisition is expected to expand Microchip’s processing portfolio for intelligent edge systems and strengthen its ability to deliver accelerated, power-efficient edge AI solutions for robotics, advanced vision processing and intelligent edge applications, including drones, robots, smart cameras, industrial automation and embedded AI systems.

Hailo has demonstrated technology leadership across both edge AI accelerators and vision systems on chip. Its products span from high performance edge deployments on specialty edge servers with local GenAI and multimodal workloads down to low-power vision processing inside a small form factor, stand-alone camera. With Hailo-8, Hailo-10 and Hailo-15, Microchip will gain a portfolio that supports classic computer vision, while adding advanced camera, ISP, DSP, video encoding and AI video stream processing capabilities for intelligent edge systems.

The Hailo acquisition brings multiple products, more than 100 current customers and an established developer community of more than 10,000 users. Its portfolio spans both edge AI accelerators and vision SoCs supporting workloads and capabilities including CNNs, transformers, LLM/VLM workloads, Image Signal Processing, DSP, H.264/H.265 encoding and AI video stream processing. 

“The acquisition of Hailo accelerates Microchip’s expansion into high-performance edge AI processing,” said Mark Reiten, Senior Corporate Vice President. “Hailo’s AI acceleration, advanced vision processing and software ecosystem directly complements Microchip’s embedded processing, FPGA, connectivity, security, power and analog portfolio. Together, we can help customers build more capable intelligent edge systems with the right balance of performance, power efficiency, reliability and system cost.” 

The transaction would also bring a demand-generation engine for edge AI adoption. Hailo’s Raspberry Pi ecosystem, gated Developer Zone, GitHub activity and community forum create a self-sustaining funnel that converts developer engagement into qualified opportunities and customer pipeline. 

“Joining Microchip would give Hailo the opportunity to scale our accelerated edge AI technology through a global embedded systems leader,” said Hailo CEO Orr Danon. “Microchip’s customer reach, channel scale and broad technology portfolio would create a strong platform for bringing advanced vision processing and AI acceleration to broader range of intelligent edge applications.” 

The agreement builds on Microchip’s strategy to enable power-efficient AI at the edge. Microchip previously expanded its AI capabilities with the acquisition of Neuronix AI Labs, which added neural network optimization technology for AI/ML workloads on FPGAs and SoCs. This transaction adds dedicated edge AI processors, vision SoCs and software tools to Microchip’s portfolio that broaden its ability to support accelerated AI and advanced vision processing at the edge. 

Cautionary Statement:

Certain statements in this release, including those relating to the expected closing date, expanding Microchip’s processing portfolio, that the acquisition accelerates Microchip’s expansion into high-performance edge AI processing, and other statements regarding the expected benefits of the transaction are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that could cause our actual results to differ materially, including, but not limited to: any economic uncertainty due to monetary policy, geopolitical or other issues in the U.S. or internationally, any unexpected fluctuations or weakness in the U.S. and global economies; changes in demand or market acceptance of our products (including Hailo products) and the products of our customers; the mix of inventory we hold and our ability to satisfy short-term orders from our inventory; changes in utilization of our manufacturing capacity and our ability to effectively manage our production levels; competitive developments including pricing pressures; the level of orders that are received and can be shipped in a quarter; changes or fluctuations in customer order patterns and seasonality; our ability to successfully integrate the operations and employees, retain key employees and customers and otherwise realize the expected synergies and benefits of the Hailo acquisition; our ability to obtain a sufficient supply of wafers from third party wafer foundries and the cost of such wafers, the costs and outcome of any current or future tax audit or any litigation involving intellectual property, customers or other issues; disruptions in our business or the businesses of our customers or suppliers due to natural disasters, terrorist activity, armed conflict, war, worldwide oil prices and supply, public health concerns or disruptions in the transportation system; and general economic, industry or political conditions in the United States or internationally. For a detailed discussion of these and other risk factors, please refer to the SEC filings of Microchip including those on Forms 10-K, 10-Q and 8-K.

You can obtain copies of such filings and other relevant documents for free at Microchip’s website (www.microchip.com) or the SEC’s website (www.sec.gov) or from commercial document retrieval services.

Stockholders are cautioned not to place undue reliance on the forward-looking statements in this press release, which speak only as of the date such statements are made. Microchip undertakes no obligation to publicly update any forward-looking statements to reflect events, circumstances or new information after the date of this press release, or to reflect the occurrence of unanticipated events.

About Microchip:


Microchip Technology Inc. is a broadline supplier of semiconductors committed to making innovative design easier through total system solutions that address critical challenges at the intersection of emerging technologies and durable end markets. Its easy-to-use development tools and comprehensive product portfolio support customers throughout the design process, from concept to completion. Headquartered in Chandler, Arizona, Microchip offers outstanding technical support and delivers solutions across the industrial, automotive, consumer, aerospace and defense, communications and computing markets. For more information, visit the Microchip website at www.microchip.com.

Note: The Microchip name and logo are registered trademarks of Microchip Technology Incorporated in the U.S.A. and other countries. All other trademarks mentioned herein are the property of their respective companies.

INVESTOR RELATIONS CONTACT:
Sajid Daudi/Head of IR (480) 792-7385